Loading...
TGTR logo

Together Pharma LtdTASE:TGTR Stock Report

Market Cap ₪40.7m
Share Price
n/a
1Y-38.2%
7D0.8%
1D-0.2%
Portfolio Value
View

Together Pharma Ltd

TASE:TGTR Stock Report

Market Cap: ₪40.7m

Together Pharma (TGTR) Stock Overview

Through its subsidiaries, engages in the cultivation, propagation, import, export, production, storage and distribution of medical cannabis products in Israel. More details

TGTR fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance3/6
Financial Health3/6
Dividends0/6

TGTR Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW493,086 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
493,086 investors already sharing narratives

Together Pharma Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Together Pharma
Historical stock prices
Current Share Price₪2.35
52 Week High₪4.15
52 Week Low₪2.14
Beta0.21
1 Month Change1.73%
3 Month Change-11.30%
1 Year Change-38.25%
3 Year Change-10.46%
5 Year Change-77.85%
Change since IPO-99.04%

Recent News & Updates

Analysis Article Dec 21

Fewer Investors Than Expected Jumping On Together Pharma Ltd (TLV:TGTR)

Together Pharma Ltd's ( TLV:TGTR ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a buy right now...
Analysis Article Oct 30

Returns On Capital Signal Difficult Times Ahead For Together Pharma (TLV:TGTR)

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...

Recent updates

Analysis Article Dec 21

Fewer Investors Than Expected Jumping On Together Pharma Ltd (TLV:TGTR)

Together Pharma Ltd's ( TLV:TGTR ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a buy right now...
Analysis Article Oct 30

Returns On Capital Signal Difficult Times Ahead For Together Pharma (TLV:TGTR)

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...
Analysis Article Jan 07

Why The 29% Return On Capital At Together Pharma (TLV:TGTR) Should Have Your Attention

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article Nov 04

Market Cool On Together Pharma Ltd's (TLV:TGTR) Revenues

When close to half the companies operating in the Interactive Media and Services industry in Israel have price-to-sales...
Analysis Article Sep 13

Is Together Pharma (TLV:TGTR) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Aug 02

Investors Holding Back On Together Pharma Ltd (TLV:TGTR)

When you see that almost half of the companies in the Interactive Media and Services industry in Israel have...
Analysis Article May 31

Together Pharma (TLV:TGTR) Is Achieving High Returns On Its Capital

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
Analysis Article Apr 04

Further Upside For Together Pharma Ltd (TLV:TGTR) Shares Could Introduce Price Risks After 49% Bounce

Together Pharma Ltd ( TLV:TGTR ) shares have continued their recent momentum with a 49% gain in the last month alone...
Analysis Article Dec 28

A Piece Of The Puzzle Missing From Together Pharma Ltd's (TLV:TGTR) Share Price

Together Pharma Ltd's ( TLV:TGTR ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a buy right now...
Analysis Article Nov 13

Returns At Together Pharma (TLV:TGTR) Are On The Way Up

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Analysis Article Oct 09

Together Pharma (TLV:TGTR) Has A Somewhat Strained Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Sep 03

Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

Despite an already strong run, Together Pharma Ltd ( TLV:TGTR ) shares have been powering on, with a gain of 35% in the...
Analysis Article Sep 03

Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

Despite an already strong run, Together Pharma Ltd ( TLV:TGTR ) shares have been powering on, with a gain of 35% in the...
Analysis Article May 27

Is Together Pharma (TLV:TGTR) Using Debt Sensibly?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Jan 05

Is Together Pharma (TLV:TGTR) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Oct 28

Together Pharma (TLV:TGTR) Is Looking To Continue Growing Its Returns On Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Analysis Article Sep 03

Is Together Pharma (TLV:TGTR) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Jul 29

Together Pharma (TLV:TGTR) Might Have The Makings Of A Multi-Bagger

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article Apr 08

Here's Why Together Pharma (TLV:TGTR) Has A Meaningful Debt Burden

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Dec 24

Can Together Pharma (TLV:TGTR) Continue To Grow Its Returns On Capital?

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...

Shareholder Returns

TGTRIL PharmaceuticalsIL Market
7D0.8%-2.0%-3.5%
1Y-38.2%-32.7%18.9%

Return vs Industry: TGTR underperformed the IL Pharmaceuticals industry which returned -32.4% over the past year.

Return vs Market: TGTR underperformed the IL Market which returned 18.6% over the past year.

Price Volatility

Is TGTR's price volatile compared to industry and market?
TGTR volatility
TGTR Average Weekly Movement4.9%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement5.6%
10% most volatile stocks in IL Market9.7%
10% least volatile stocks in IL Market3.7%

Stable Share Price: TGTR has not had significant price volatility in the past 3 months compared to the IL market.

Volatility Over Time: TGTR's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1991210Nissim Brachawww.together-pharma.com

Together Pharma Ltd, through its subsidiaries, engages in the cultivation, propagation, import, export, production, storage and distribution of medical cannabis products in Israel. It offers cannabis oils and inflorescences. The company was incorporated in 1991 and is based in Ashkelon, Israel.

Together Pharma Ltd Fundamentals Summary

How do Together Pharma's earnings and revenue compare to its market cap?
TGTR fundamental statistics
Market cap₪40.70m
Earnings (TTM)₪1.91m
Revenue (TTM)₪109.63m
21.3x
P/E Ratio
0.4x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TGTR income statement (TTM)
Revenue₪109.63m
Cost of Revenue₪78.14m
Gross Profit₪31.49m
Other Expenses₪29.58m
Earnings₪1.91m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.11
Gross Margin28.72%
Net Profit Margin1.74%
Debt/Equity Ratio94.8%

How did TGTR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/13 07:21
End of Day Share Price 2026/07/10 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Together Pharma Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.